Hinge Health, Inc. Class A(HNGE)
$120.99-0.73 (-0.60%)
HNGE
Hinge Health, Inc. Class A financials statements
$120.99
At close:-0.73 (-0.60%)
Want to see HNGE full AI Analyst Report?
Hinge Health, Inc. Class A (HNGE) Ratios
261 Followers
Hinge Health, Inc. Class A Ratios
HNGE's free cash flow for Q3 2026 was $112.66M. For the 2026 fiscal year, HNGE's free cash flow was decreased by $-1.94M and operating cash flow was $114.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 1.47 | 2.34 | 2.88 |
| Quick Ratio | 1.43 | 2.30 | 2.81 |
| Cash Ratio | 0.57 | 1.21 | 1.28 |
| Solvency Ratio | -1.43 | -0.04 | -0.53 |
| Operating Cash Flow Ratio | 0.47 | 0.20 | -0.35 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 167.68M | $ 326.89M | $ 334.63M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.97 | 1.62 | 1.46 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.14 | 0.20 |
| Net Debt to EBITDA | 0.37 | 13.12 | 2.13 |
| Profitability Margins | |||
| Gross Profit Margin | 79.83% | 77.00% | 66.33% |
| EBIT Margin | -92.03% | -6.26% | -37.08% |
| EBITDA Margin | -91.16% | -5.66% | -35.16% |
| Operating Profit Margin | -92.94% | -8.17% | -44.59% |
| Pretax Profit Margin | -89.69% | -2.88% | -37.08% |
| Net Profit Margin | -89.86% | -3.06% | -36.94% |
| Continuous Operations Profit Margin | -89.86% | -3.06% | -36.94% |
| Net Income Per EBT | 100.19% | 106.01% | 99.63% |
| EBT Per EBIT | 96.50% | 35.27% | 83.17% |
| Return on Assets (ROA) | -70.93% | -1.77% | -17.37% |
| Return on Equity (ROE) | -139.55% | -2.86% | -25.31% |
| Return on Capital Employed (ROCE) | -142.90% | -7.53% | -29.77% |
| Return on Invested Capital (ROIC) | -141.34% | -7.46% | -29.35% |
| Return on Tangible Assets | -77.90% | -1.96% | -19.35% |
| Earnings Yield | -14.36% | -0.41% | -3.69% |
| Efficiency Ratios | |||
| Receivables Turnover | 8.90 | 9.19 | 6.29 |
| Payables Turnover | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 7.58 | 8.26 | 7.41 |
| Fixed Asset Turnover | 33.88 | 22.98 | 13.02 |
| Asset Turnover | 0.79 | 0.58 | 0.47 |
| Working Capital Turnover Ratio | 2.33 | 1.15 | 0.00 |
| Cash Conversion Cycle | 89.15 | 83.92 | 107.29 |
| Days of Sales Outstanding | 41.02 | 39.73 | 58.06 |
| Days of Inventory Outstanding | 48.14 | 44.19 | 49.23 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 89.15 | 83.92 | 107.29 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 2.16 | 0.63 | -0.82 |
| Free Cash Flow Per Share | 2.16 | 0.58 | -0.88 |
| Dividend Paid and CapEx Coverage Ratio | 242.15 | 12.99 | -13.85 |
| Capital Expenditure Coverage Ratio | 242.15 | 12.99 | -13.85 |
| Operating Cash Flow Coverage Ratio | 21.33 | 4.43 | -4.06 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.13 | -0.22 |
| Free Cash Flow Yield | 4.64% | 1.54% | -2.34% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -8.67 | -250.40 | -27.10 |
| Price-to-Sales (P/S) Ratio | 6.26 | 7.51 | 10.01 |
| Price-to-Book (P/B) Ratio | 9.72 | 7.03 | 6.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.54 | 64.79 | -42.76 |
| Price-to-Operating Cash Flow Ratio | 21.46 | 59.80 | -45.85 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 2.81 | 0.00 |
| Enterprise Value Multiple | -6.49 | -119.60 | -26.34 |
| Enterprise Value | 3.48B | 2.64B | 2.71B |
| EV to EBITDA | -6.49 | -119.60 | -26.34 |
| EV to Sales | 5.92 | 6.76 | 9.26 |
| EV to Free Cash Flow | 20.37 | 58.38 | -39.56 |
| EV to Operating Cash Flow | 20.29 | 53.89 | -42.42 |
| Tangible Book Value Per Share | 3.94 | 4.53 | 4.66 |
| Shareholders’ Equity Per Share | 4.78 | 5.34 | 5.48 |
| Tax and Other Ratios | |||
| Effective Tax Rate | -0.00 | -0.06 | 0.00 |
| Revenue Per Share | 7.42 | 5.00 | 3.75 |
| Net Income Per Share | -6.67 | -0.15 | -1.39 |
| Tax Burden | 1.00 | 1.06 | 1.00 |
| Interest Burden | 0.97 | 0.46 | 1.00 |
| Research & Development to Revenue | 0.63 | 0.26 | 0.38 |
| SG&A to Revenue | 1.09 | 0.58 | 0.00 |
| Stock-Based Compensation to Revenue | 1.09 | 0.00 | 0.01 |
| Income Quality | -0.32 | -4.11 | 0.59 |
Currency in USD
